Cerus Corporation (CERS) vs Ovid Therapeutics Inc. (OVID)
A side-by-side comparison of Cerus Corporation and Ovid Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CERS
Cerus Corporation
$2.34HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
OVID
Ovid Therapeutics Inc.
$2.37HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CERS vs OVID
growth of $100 · dividends reinvested · last 9yCERS -44.8% (-6.4%/yr)OVID -80.9% (-16.8%/yr)CERS compounded faster over this window
CERS OVID
CERS vs OVID: by the numbers
- •CERS is the larger company ($472M vs $442M market cap).
- •Both run net losses; CERS's is the smaller (-3.06% vs -2178.90% net margin).
- •CERS grew revenue faster over the past five years (15.74% vs -62.76% CAGR).
Metrics side by side
Valuation
| Metric | CERS | OVID |
|---|---|---|
| P/S ratio | 2.13 | 279.43 |
| P/B ratio | 6.73 | 2.11 |
| EV / EBITDA | 8036.17 | N/A |
Profitability
| Metric | CERS | OVID |
|---|---|---|
| Gross margin | 52.05% | 100.00% |
| Operating margin | -0.73% | -585.20% |
| Net margin | -3.06% | -2178.90% |
| ROE | -9.69% | -16.43% |
| ROIC | -1.08% | -26.29% |
Growth (annualized)
| Metric | CERS | OVID |
|---|---|---|
| Revenue CAGR (5Y) | 15.74% | -62.76% |
| Total return CAGR (5Y) | -17.30% | -6.98% |
Frequently asked
- Which has grown faster, CERS or OVID?
- Over the past five years, CERS grew revenue faster — CERS at a 15.74% CAGR versus OVID at -62.76%.
- How have CERS and OVID total returns compared?
- Over the past 5 years, CERS delivered -17.30% and OVID delivered -6.98% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cerus ROEOvid Therapeutics ROECerus operating marginOvid Therapeutics operating marginCerus revenue growthOvid Therapeutics revenue growthCerus free cash flowOvid Therapeutics free cash flow
Cerus & Ovid Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.